cyclobenzaprine has been researched along with Colitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abedi, V; Bassaganya-Riera, J; Carbo, A; Girardin, S; Godfrey, V; Heltzel, C; Hontecillas, R; Kale, S; Langowski, M; Leber, A; Lu, P; Philipson, C; Tubau-Juni, N; Uren, A | 1 |
Boussetta, T; Driss, F; El-Benna, J; Gougerot-Pocidalo, MA; Lettéron, P; Marie, JC; Raad, H | 1 |
2 other study(ies) available for cyclobenzaprine and Colitis
Article | Year |
---|---|
Modeling-Enabled Characterization of Novel NLRX1 Ligands.
Topics: Animals; Anti-Inflammatory Agents; Colitis; Drug Evaluation, Preclinical; Fatty Acids; Gene Expression Regulation; Humans; Ligands; Linolenic Acids; Mice; Mitochondrial Proteins; Molecular Docking Simulation; Mutation; NF-kappa B; Peptide Fragments; Protein Structure, Tertiary | 2015 |
Punicic acid a conjugated linolenic acid inhibits TNFalpha-induced neutrophil hyperactivation and protects from experimental colon inflammation in rats.
Topics: Animals; Colitis; Linolenic Acids; Lymphocyte Activation; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophils; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2009 |